Allurion Technologies (ALUR) Price & Analysis

Compare

297 Followers

ALUR Stock Chart & Stats

$1.26

-$0.76(-9.72%)

At close: Jan 08 4:00 PM EST

$1.26

-$0.76(-9.72%)

Day’s Range― - ―

52-Week Range$1.02 - $16.81

Previous CloseN/A

Volume63.90K

Average Volume (3M)349.87K

Market Cap

$13.89M

Enterprise Value$43.17M

Total Cash (Recent Filing)$6.14M

Total Debt (Recent Filing)$33.39M

Price to Earnings (P/E)―

Beta2.70

Next Earnings

Mar 19, 2026

EPS Estimate

-0.72

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.53

Shares Outstanding9,262,586

10 Day Avg. Volume46,144

30 Day Avg. Volume349,872

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)-0.31

Price to Sales (P/S)0.75

P/FCF Ratio-0.56

Enterprise Value/Market Cap3.11

Enterprise Value/Revenue2.51

Enterprise Value/Gross Profit4.11

Enterprise Value/Ebitda-1.29

Forecast

1Y Price Target

$6.00

Price Target Upside376.19% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-4.2

Revenue Forecast (FY)$14.54M

Bulls Say, Bears Say

Bulls Say

Cost ManagementOperating expenses of $9.4M were down 48% year over year, as the company continues to closely control spending while prioritizing its growth initiatives.

Sales PerformanceQ3 sales were $2.7M vs the $2.1M Street estimate.

Strategic RealignmentALUR used the quarter to implement the strategy it outlined in August of realigning toward distributors with physician networks that prescribe GLP-1s.

Bears Say

Gross Margin DeclineQ3 gross margin was 49%, down from 58% last year due to the decline in sales and lower production volumes leading to less absorption of labor and overhead costs.

Revenue ShortfallRevenue was $3.4M, which fell short of the $5.2M consensus.

Sales ImpactSales were hurt by the intra-quarter decision to realign toward distributors with physician networks that prescribe GLP-1s.

Allurion Technologies News

Allurion reports initial results on Allurion Program, tirzepatide combination

Allurion Technologies (ALUR) announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to...

25d ago

ALUR

Allurion Shareholders Approve Governance Changes and Capital Actions

Allurion Technologies ( ($ALUR) ) has shared an announcement. At its annual meeting on December 18, 2025, Allurion...

13h ago

ALUR

Allurion partners with ProSurg to pioneer new weight loss approach in Brazil

Allurion Technologies (ALUR) announced a strategic distribution partnership with ProSurg Medical, a Brazilian medical device company specializing in...

1M ago

ALUR

Allurion Technologies Delays Q3 2025 Report Filing

Allurion Technologies ( ($ALUR) ) has released a notification of late filing. Allurion Technologies, Inc. has announced a...

1M ago

ALUR

Allurion Technologies Reports Q3 2025 Financial Results

Allurion Technologies, Inc. ( ($ALUR) ) has released its Q3 earnings. Here is a breakdown of the information...

1M ago

ALUR

Allurion Technologies’ Earnings Call: Progress Amid Challenges

Allurion Technologies, Inc. (($ALUR)) has held its Q3 earnings call. Read on for the main highlights of the...

1M ago

ALUR

Allurion Technologies: Strong Q3 Performance and Strategic Shifts Drive Buy Rating

Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on Allurion Technologies. The associated price target...

1M ago

ALUR

Allurion Technologies Secures $5M in New Funding

An update from Allurion Technologies ( ($ALUR) ) is now available. On November 11, 2025, Allurion Technologies entered...

1M ago

ALUR

Allurion Technologies reports Q3 EPS ($1.53), consensus ($2.45)

Reports Q3 revenue $2.66M, consensus $2.05M. “In this past quarter at Allurion, we achieved several significant milestones toward...

1M ago

ALUR

Allurion Technologies provides update on Smart Capsule approval process

Allurion Technologies (ALUR) announced it has passed critical milestones in the FDA pre-market approval process for the Allurion...

1M ago

ALUR

Allurion Technologies publishes Smart Capsule study data in Obesity Surgery

Allurion Technologies (ALUR) announced the publication of the first peer-reviewed study on the consecutive use of the Allurion...

2M ago

ALUR

Medtimo files patent infringement complaint against Allurion Technologies

Medtimo announced that it has filed a patent infringement complaint in the U.S. District Court of the District...

3M ago

ALUR

Allurion Technologies’ Earnings Call: Strategic Shift Amid Revenue Challenges

Allurion Technologies, Inc. (($ALUR)) has held its Q2 earnings call. Read on for the main highlights of the...

4M ago

ALUR

Eight option delistings on August 18th

Option delistings effective August 18th include Q32 Bio Inc (QTTB), Hyperdynamics Corp (HYPD), Bionano Genomics (BNGO), Allurion Technologies...

4M ago

ABTS

ALUR

ALUR FAQ

What was Allurion Technologies, Inc.’s price range in the past 12 months?

Allurion Technologies, Inc. lowest stock price was $1.02 and its highest was $16.81 in the past 12 months.

What is Allurion Technologies, Inc.’s market cap?

Allurion Technologies, Inc.’s market cap is $13.89M.

When is Allurion Technologies, Inc.’s upcoming earnings report date?

Allurion Technologies, Inc.’s upcoming earnings report date is Mar 19, 2026 which is in 89 days.

How were Allurion Technologies, Inc.’s earnings last quarter?

Allurion Technologies, Inc. released its earnings results on Nov 12, 2025. The company reported -$1.53 earnings per share for the quarter, beating the consensus estimate of -$1.97 by $0.44.

Is Allurion Technologies, Inc. overvalued?

According to Wall Street analysts Allurion Technologies, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Allurion Technologies, Inc. pay dividends?

Allurion Technologies, Inc. does not currently pay dividends.

What is Allurion Technologies, Inc.’s EPS estimate?

Allurion Technologies, Inc.’s EPS estimate is -0.72.

How many shares outstanding does Allurion Technologies, Inc. have?

Allurion Technologies, Inc. has 9,262,586 shares outstanding.

What happened to Allurion Technologies, Inc.’s price movement after its last earnings report?

Allurion Technologies, Inc. reported an EPS of -$1.53 in its last earnings report, beating expectations of -$1.97. Following the earnings report the stock price went up 0.671%.

Which hedge fund is a major shareholder of Allurion Technologies, Inc.?

Currently, no hedge funds are holding shares in ALUR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Allurion Technologies, Inc.

Allurion Technologies (ALUR) is a medical technology company focused on developing innovative solutions for weight management and obesity treatment. The company operates primarily in the healthcare sector, offering a range of products aimed at helping individuals achieve sustainable weight loss. Its core product, the Allurion Balloon, is an intragastric balloon that aids in weight loss by promoting a feeling of fullness, and is part of a comprehensive program that includes lifestyle coaching and nutritional support.

Allurion Technologies (ALUR) Earnings & Revenues

Historic Earnings Reports

ALUR Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The call highlighted significant progress in the FDA approval process and successful restructuring efforts that improved financial efficiencies. However, these positives were tempered by a considerable decline in revenue and gross profit. The company's strategic initiatives, such as debt restructuring and R&D advancements, indicate a positive long-term outlook.View all ALUR earnings summaries

ALUR Stock 12 Month Forecast

Average Price Target

$6.00

▲(376.19% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","11":"$11","2.75":"$2.75","5.5":"$5.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.75,5.5,8.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.46,1.8092307692307692,2.1584615384615384,2.5076923076923077,2.856923076923077,3.206153846153846,3.5553846153846154,3.9046153846153846,4.253846153846154,4.603076923076923,4.952307692307692,5.3015384615384615,5.650769230769231,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.46,1.8092307692307692,2.1584615384615384,2.5076923076923077,2.856923076923077,3.206153846153846,3.5553846153846154,3.9046153846153846,4.253846153846154,4.603076923076923,4.952307692307692,5.3015384615384615,5.650769230769231,{"y":6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.46,1.8092307692307692,2.1584615384615384,2.5076923076923077,2.856923076923077,3.206153846153846,3.5553846153846154,3.9046153846153846,4.253846153846154,4.603076923076923,4.952307692307692,5.3015384615384615,5.650769230769231,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.15,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.88,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.18,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.31,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.33,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.72,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.76,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.06,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.85,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.46,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >